FDA, Docket No
People with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2), whether personal or familial, should steer clear of this medication because of the associated thyroid cancer risk
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: biochemical role as a component of glutathione peroxidase
#DigitalHealth #GLP1 #HealthcareInnovation #WeightLoss #HealthTech Digital health companies seek lasting edge amid GLP-1 gold rush | TechTarget techtarget.com To view or add a comment, sign in Omada Health joins Eli Lilly and Company ecosystem around Zepbound Through Lilly's Employer Connect programme, employers can now offer Omada's GLP-1 Care Track alongside Zepbound as a bundled benefit, combining the drug itself with structured digital support covering coaching, strength training, body composition tracking and AI-powered nutrition guidance
Extreme/rapid weight loss may result in nutritional deficiencies that lead to hair loss, anemia, weak bones, or increased risk of infection
Michael Snyder, was recently featured in Men's Journal to discuss the emergence of "GLP-3s"